178 related articles for article (PubMed ID: 17365669)
1. Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability.
Frisbee JC; Samora JB; Basile DP
Microcirculation; 2007 Feb; 14(2):145-53. PubMed ID: 17365669
[TBL] [Abstract][Full Text] [Related]
2. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.
Frisbee JC
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R307-R316. PubMed ID: 15802560
[TBL] [Abstract][Full Text] [Related]
3. Exercise training blunts microvascular rarefaction in the metabolic syndrome.
Frisbee JC; Samora JB; Peterson J; Bryner R
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2483-92. PubMed ID: 16798823
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin releases a substance from the aorta that dilates an isolated arteriole by up-regulating INOS.
Viol AW; Prewitt RL; Doviak M; Britt LD
J Surg Res; 2005 Aug; 127(2):106-11. PubMed ID: 15921695
[TBL] [Abstract][Full Text] [Related]
5. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production.
Yang HT; Yan Z; Abraham JA; Terjung RL
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1097-104. PubMed ID: 11179052
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin: a negative regulator of endothelial-dependent vasodilation.
Koshida R; Ou J; Matsunaga T; Chilian WM; Oldham KT; Ackerman AW; Pritchard KA
Circulation; 2003 Feb; 107(6):803-6. PubMed ID: 12591747
[TBL] [Abstract][Full Text] [Related]
7. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
8. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries.
Dumont O; Loufrani L; Henrion D
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):317-24. PubMed ID: 17158349
[TBL] [Abstract][Full Text] [Related]
9. Comparative haemodynamic studies of resting and active skeletal muscle in anaesthetised rats: role of nitric oxide.
Hably C; Vág J; Bartha J
Acta Physiol Hung; 2001; 88(1):25-33. PubMed ID: 11811844
[TBL] [Abstract][Full Text] [Related]
10. Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles.
Spier SA; Delp MD; Meininger CJ; Donato AJ; Ramsey MW; Muller-Delp JM
J Physiol; 2004 May; 556(Pt 3):947-58. PubMed ID: 15004211
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Vascular Control During Exercise: Impact of Nitrite Infusion During Nitric Oxide Synthase Inhibition in Healthy Rats.
Ferguson SK; Glean AA; Holdsworth CT; Wright JL; Fees AJ; Colburn TD; Stabler T; Allen JD; Jones AM; Musch TI; Poole DC
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):201-8. PubMed ID: 26272082
[TBL] [Abstract][Full Text] [Related]
12. Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats.
Ross RM; Wadley GD; Clark MG; Rattigan S; McConell GK
Diabetes; 2007 Dec; 56(12):2885-92. PubMed ID: 17881613
[TBL] [Abstract][Full Text] [Related]
13. Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles.
Delp MD; Behnke BJ; Spier SA; Wu G; Muller-Delp JM
J Physiol; 2008 Feb; 586(4):1161-8. PubMed ID: 18063659
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibition during treadmill exercise reveals fiber-type specific vascular control in the rat hindlimb.
Copp SW; Hirai DM; Hageman KS; Poole DC; Musch TI
Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R478-85. PubMed ID: 20007515
[TBL] [Abstract][Full Text] [Related]
15. Role of neuronal nitric oxide in the inhibition of sympathetic vasoconstriction in resting and contracting skeletal muscle of healthy rats.
Jendzjowsky NG; DeLorey DS
J Appl Physiol (1985); 2013 Jul; 115(1):97-106. PubMed ID: 23640592
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide.
Matsunaga T; Weihrauch DW; Moniz MC; Tessmer J; Warltier DC; Chilian WM
Circulation; 2002 May; 105(18):2185-91. PubMed ID: 11994253
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of flow and ACh-induced dilation in rat soleus arterioles are altered by hindlimb unweighting.
Schrage WG; Woodman CR; Laughlin MH
J Appl Physiol (1985); 2002 Mar; 92(3):901-11. PubMed ID: 11842020
[TBL] [Abstract][Full Text] [Related]
18. Vasodilatation, oxygen delivery and oxygen consumption in rat hindlimb during systemic hypoxia: roles of nitric oxide.
Edmunds NJ; Marshall JM
J Physiol; 2001 Apr; 532(Pt 1):251-9. PubMed ID: 11283239
[TBL] [Abstract][Full Text] [Related]
19. Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo.
Bradley EA; Richards SM; Keske MA; Rattigan S
Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E745-50. PubMed ID: 23900417
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
